5,181
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Pollution prevention in the pharmaceutical industry

, &
Pages 344-351 | Received 31 Jul 2012, Accepted 27 Aug 2012, Published online: 18 Dec 2012

REFERENCES

  • Anastas, P. and Kirchhoff, M.M., 2002. Origins, current status, and future challenges of green chemistry. Accounts of Chemical Research, 35 (9), 686–694.
  • Datamonitor, 2010. Industry profile global pharmaceuticals. www.datamonitor.com.
  • Environmental Protection Agency (EPA), 1997. Profile of the pharmaceutical manufacturing industry. Washington, DC: EPA 310-R-97-005.
  • Everaert, K. and Baeyens, J., 2008. The pharmaceutical industry, Preventieve Pollutiebeperking van Processen. Belgium: Wolters Kluwer, 123–129, ISBN 978-90-4651-959-2 (in Dutch), Chapter 4.
  • Grassman, O., Reepmeyer, G., and Von Zedtwitz, M., 2008. Leading pharmaceutical innovation; trends and drivers for growth in the pharmaceutical industry. Leipzig: Springer.
  • ICF Technology, Inc., 1991. Guides to pollution prevention: the pharmaceutical industry. EPA/625/7-91/017;10/91.
  • Li, Z.D., Zhang, S.S., Zhang, Y., Zhang, Y., and Wei, L., 2011. Evaluation of clearner production audit in pharmaceutical production industry: case study of the pharmaceutical plant in Dalian, P.R. China. Clean Technologies and Environmental Policy, 13 (1), 195–206.
  • Nicponski, D.R. and Ramachandran, P.V., 2011. The role of solvent selection at exploratory and production stages in the pharmaceutical industry. Future Medicinal Chemistry, 3 (12), 1469–1473.
  • Pharmaceutical Industry, 2012. Available from: www.pharmaceutical-industry.info (consulted on 27 July 2012).
  • PhRMA, 2012. Available from: http://www.phrma.org/illustrative-pharmaceutical-lifecycle (consulted on 27 July 2012).
  • Raymond, M.J., Slater, C.S., and Savelski, M.J., 2010. LCA approach to the analysis of solvent waste issues in the pharmaceutical industry. Green Chemistry, 12 (10), 1826–1834.
  • Shearouse, W.C., Wassell, D.C., and Mack, J., 2009. Alternative solvent-free methodologies in the synthesis of pharmaceutical drugs. Current Opinion in Drug Discovery and Development, 12 (6), 772–783.
  • Thissen, N., 2010. Mass and energy flow analysis supports process improvement. Chemical Engineering and Technology, 33 (4), 573–581.
  • Von Zahren, W.M., 1996. ISO 14000: Understanding the environmental standards. Rockville, MD: Government Institutes, Inc.
  • Welch, C.J., 2007. Challenges and opportunities for the greening of separation science in the pharmaceutical industry. Drug Discovery World, 8 (4), 71–77.
  • Wikipedia, 2012. Available from: en.wikipedia.org/pharmaceutical_industry (consulted on 27 July 2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.